Press Releases Year None202120202019 October 7, 2021 Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment October 1, 2021 Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting September 2, 2021 Ikena Oncology to Participate in September 2021 Virtual Investor Conferences August 12, 2021 Ikena Oncology Reports Second Quarter 2021 Financial Results and Provides Update on Key Programs July 8, 2021 Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021 May 26, 2021 Ikena Oncology to Participate in the 2021 Jefferies Virtual Healthcare Conference May 13, 2021 Ikena Oncology Reports First Quarter 2021 Financial Results and Outlines Key Corporate Objectives for 2021 April 15, 2021 Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors March 30, 2021 Ikena Oncology Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares March 25, 2021 Ikena Oncology Announces Pricing of Initial Public Offering Pagination Current page 1 Page 2 Next page next › Last page last » Site - Side Corporate Profile Press Releases Events & Presentations Stock Information Stock Quote & Chart Historic Price Lookup Analyst Coverage Financial Filings SEC Filings Corporate Governance Documents & Charters Management Team Board of Directors Investor Resources Investor FAQs Investor Email Alerts Contact IR Investors & Media Contact Rebecca Cohen rcohen@ikenaoncology.com Tools Print Page Email Alerts RSS Feeds
Year None202120202019 October 7, 2021 Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment October 1, 2021 Ikena Oncology to Present a Trial-in-Progress Update, Translational Data, and Indication Selection Methodology for Novel AHR Inhibition Program at the 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting September 2, 2021 Ikena Oncology to Participate in September 2021 Virtual Investor Conferences August 12, 2021 Ikena Oncology Reports Second Quarter 2021 Financial Results and Provides Update on Key Programs July 8, 2021 Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021 May 26, 2021 Ikena Oncology to Participate in the 2021 Jefferies Virtual Healthcare Conference May 13, 2021 Ikena Oncology Reports First Quarter 2021 Financial Results and Outlines Key Corporate Objectives for 2021 April 15, 2021 Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors March 30, 2021 Ikena Oncology Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares March 25, 2021 Ikena Oncology Announces Pricing of Initial Public Offering Pagination Current page 1 Page 2 Next page next › Last page last »
